Precipio (NASDAQ: PRPO)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-11 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.200 | ||||||
REV | 2.447M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Precipio (NASDAQ: PRPO) through any online brokerage.
Other companies in Precipio’s space includes: Aesthetic Medical Intl (NASDAQ:AIH), Psychemedics (NASDAQ:PMD), Star Equity Hldgs (NASDAQ:STRR), Novo Integrated Sciences (NASDAQ:NVOS) and Akumin (NASDAQ:AKU).
The latest price target for Precipio (NASDAQ: PRPO) was reported by Maxim Group on Friday, November 22, 2019. The analyst firm set a price target for 4.00 expecting PRPO to rise to within 12 months (a possible 247.55% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Precipio (NASDAQ: PRPO) is $1.1509 last updated Today at June 28, 2022, 4:24 PM UTC.
There are no upcoming dividends for Precipio.
Precipio’s Q2 earnings are confirmed for Thursday, August 11, 2022.
There is no upcoming split for Precipio.
Precipio is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.